Science Health Tips Insight: Jan 29, 2026
The GLP-1 Agonists Trend: A Deep Dive into the Science, Hype, and Realities The explosion of GLP-1 receptor agonist medications, such as Ozempic, Mounjaro, Wegovy, and Zepbound, has dominated headlines and health discussions in early 2026. Originally developed for type 2 diabetes management, these once-weekly injectables have become a viral sensation for their potent effects …